Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amyloid-beta fibrils as active contributors to synaptic dysfunction in Alzheimer's disease.

Acta pharmacologica Sinica·2026
Same author

Irisin as a driver of neuroprotection in multiple sclerosis.

Nature metabolism·2026
Same author

The multifaceted role of ASICs channels into the nervous system and their potential use as a therapeutic target for neuro-disorders.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Targeting brain colony stimulating factor 1 receptor for phagocytic microglia reprogramming as a potential strategy against brain inflammation.

Neural regeneration research·2026
Same author

Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement.

Brain, behavior, and immunity·2026
Same author

Ellagic acid-loaded nanovesicles rescue LTP impairment and neuroinflammation in an AD ex-vivo model.

European journal of pharmacology·2025

Related Experiment Video

Updated: May 14, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.

Robert Nisticò1, Dalila Mango, Georgia Mandolesi

  • 1IRCSS Fondazione Santa Lucia, Rome, Italy. robert.nistico@uniroma1.it

Plos One
|January 29, 2013
PubMed
Summary

Neuroinflammation in experimental autoimmune encephalomyelitis (EAE) alters hippocampal synaptic plasticity, favoring long-term potentiation over long-term depression. This involves interleukin-1β signaling and impacts GABAergic transmission, potentially explaining cognitive deficits in multiple sclerosis (MS).

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
08:17

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis

Published on: February 23, 2024

Related Experiment Videos

Last Updated: May 14, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
08:17

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis

Published on: February 23, 2024

Area of Science:

  • Neuroscience
  • Immunology
  • Synaptic Plasticity

Background:

  • Abnormal synaptic plasticity underlies memory deficits in neurodegenerative diseases.
  • The role of synaptic plasticity in neuroinflammatory conditions like multiple sclerosis (MS) remains unclear.
  • Experimental autoimmune encephalomyelitis (EAE) serves as a mouse model for MS.

Purpose of the Study:

  • To investigate alterations in hippocampal synaptic plasticity during EAE.
  • To explore the role of interleukin-1β (IL-1β) and microglial activation in these changes.
  • To understand the neurobiological basis of cognitive deficits in EAE and potentially MS.

Main Methods:

  • Electrophysiological recordings in hippocampal slices from EAE and control mice.
  • Assessment of long-term potentiation (LTP) and long-term depression (LTD) induction.
  • Analysis of inhibitory postsynaptic currents (IPSCs) and neuronal oscillations.
  • Investigation of IL-1β effects and microglial activation in brain tissue.

Main Results:

  • EAE mice exhibited altered synaptic plasticity, favoring LTP over LTD in the hippocampus.
  • Interleukin-1β (IL-1β) perfusion enhanced LTP and inhibited GABAergic transmission in control mice.
  • EAE was associated with reduced GABAergic inhibition, loss of GABAergic interneurons, and decreased gamma oscillations.
  • Microglial activation in EAE correlated with IL-1β expression, mimicking GABAergic alterations.

Conclusions:

  • Neuroinflammation in EAE significantly disrupts hippocampal synaptic plasticity and GABAergic transmission.
  • Interleukin-1β signaling, driven by microglial activation, plays a key role in these synaptic alterations.
  • These findings offer insights into the mechanisms of cognitive dysfunction in EAE and MS.